Navigation Links
Parker Waichman LLP Represents Pennsylvania Man in Lawsuit Alleging Actos Caused his Bladder Cancer
Date:6/7/2013

New York, New York (PRWEB) June 07, 2013

Parker Waichman LLP, a national law firm dedicated to protecting the victims of defective drugs, has filed a lawsuit on behalf of a Pennsylvania man who allegedly developed bladder cancer after taking the diabetes drug Actos (pioglitazone). The suit was filed on May 23rd in the U.S. District Court for the Western District of Louisiana (Case No. 6:13-cv-1170) as part of the multidistrict litigation entitled In Re: Actos (Pioglitazone) Products Liability Litigation (6:11-md-2299). Takeda Pharmaceuticals, America; Takeda Pharmaceuticals USA, Inc. f/k/a Takeda Pharmaceuticals North America, Inc.; Takeda Pharmaceutical Company Limited; and Eli Lilly and Company have been named as Defendants.

According to the Complaint, the Plaintiff started taking Actos in November 2003 to treat his Type 2 diabetes. By August 2006, he was diagnosed with bladder cancer. The suit alleges that Actos caused the bladder cancer due to its defective nature. Furthermore, the suit alleges that the Defendants knew about the risk of bladder cancer but failed to disclose this information to consumers in order to protect financial interests. The Plaintiff is alleging that Actos caused pain and suffering, emotional distress and economic damages in the form of medical expenses and lost wages. The suit is also seeking damages for loss of consortium on behalf of the Plaintiff’s spouse.

In June 2011, the U.S. Food and Drug Administration (FDA) warned that taking Actos for more than a year could significantly increase the risk of bladder cancer. The safety label on Actos was updated to address this risk*. Additional research supports the link between Actos and bladder cancer. Last May, a study in the British Medical Journal** found that Actos users were twice as likely to develop bladder cancer after two years. That July, the Canadian Medical Association Journal*** found that patients taking the medication were
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2

Related medicine news :

1. Parker Waichman LLC Applauds Seniors for their Role in Helping to Recover $14.9 billion in Medicare Fraud over the Past Four Years
2. Parker Waichman LLP’s Jordan Chaikin Is Appointed to the Executive Committee of the Plaintiff’s Leadership Team in Emerson Electric Co. Wet/Dry Vac Litigation
3. Woman with Bilateral DePuy Pinnacle Hip Implant Alleges Metal Hips are Flawed in Lawsuit Filed by Parker Waichman LLP
4. Atlantic City Hotel’s Negligence Caused Conditions that Led to Serious Injuries, Alleges Lawsuit Filed by Parker Waichman LLP
5. Parker Waichman LLP Files Appeal over the Pennsylvania Department of Environmental Protection’s Ruling that Natural Gas Wells Did not Harm Couple's Drinking Water Supply
6. Parker Waichman LLP Designated as Co-Lead Counsel in the Consolidation of Hurricane Sandy-related Litigation Against the Long Island Power Authority and/or National Grid
7. Medtronic Infuse Lawsuit News: Parker Waichman LLP Alerts the Public to the June Release of Yale’s Infuse Bone Graft Study
8. Diabetes Drug Byetta Caused Arkansas Man’s Pancreatic Cancer and Resulting Injuries, Alleges Lawsuit Filed by Parker Waichman LLP and Co-Counsel
9. Mirena IUD Lawsuit Update: Supreme Court of New Jersey Centralizes Litigation; Parker Waichman LLP Underscores the Advantages of this Decision
10. DePuy Pinnacle Hip Implant Caused Elevated Ion Levels, Revision Surgery, Alleges Lawsuit Filed by Parker Waichman LLP
11. DePuy ASR Lawsuit Update: Parker Waichman LLP Commends Judge’s Refusal of Appeal for New Trial; DePuy Still Must Pay $8.3 Million Verdict
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... 2015 Padre Murphy's and Owner Tom Boyle ... Pro Player Health Alliance (PPHA). The PPHA's passion for ... everyone, including NFL greats, treated for obstructive sleep apnea (OSA) ... supporting the cause in the valley. The most recent plans ...
(Date:1/22/2015)... 22, 2015 Blue Cross and Blue Shield ... exemplify what it means to “Live Fearless.” , ... to share their stories about how they or someone they ... others by living in the moment. By telling these types ...
(Date:1/22/2015)... A new white paper by The Beryl ... the long-term care environment as well as provides recommendations ... paper, “The Power of Person-Centeredness in Long-Term Care: A ... the patient, resident and family experience in long-term care ...
(Date:1/22/2015)... 2015 Carinsurancesavings.biz has released a new blog ... dismemberment insurance . , Purchasing an accidental death and ... advantageous. This type of rider provides benefits if the insured ... considered a lesser form of life insurance. , AD&D ...
(Date:1/22/2015)... Recently, Weddingshe.com has added many trendy Champagne wedding ... revenues in the past three years. Today, the business announces ... According to the sales manager of the company, this is ... 2015. This point can be reflected on the discounted wedding ...
Breaking Medicine News(10 mins):Health News:Padre Murphy's Holds NFL Retired Players Association Party Star Studded Event With Bud Light and Pro Player Health Alliance Sponsoring 2Health News:Padre Murphy's Holds NFL Retired Players Association Party Star Studded Event With Bud Light and Pro Player Health Alliance Sponsoring 3Health News:Blue Cross and Blue Shield of Minnesota to Showcase “Faces of Fearless” 2Health News:The Power of Person-Centeredness in Long-Term Care Explored by The Beryl Institute 2Health News:The Power of Person-Centeredness in Long-Term Care Explored by The Beryl Institute 3Health News:Accidental Death and Dismemberment Insurance Can Be Purchased at Low Prices Online 2Health News:Weddingshe Announces A Special Offer On Its Popular Glamorous Wedding Dresses 2
... 1, Health Carrier Review Act Puts New Resource on the ... Carrier , BOISE, Idaho, Dec. 30 Idaho consumers ... necessary health and medical services will have a new tool ... Health Carrier External Review Act, starting January 1, the Idaho ...
... ... Advantage, a Division of Catalina Lifesciences, Inc. Announces The Promotion of Bret Petkus to ... ... of Catalina Lifesciences, Inc. Announces The Promotion of Bret Petkus to Vice-President of North ...
... , , ALISO VIEJO, Calif., ... ) today announced that the U.S. Food and Drug Administration ... seeking marketing approval for the investigational drug retigabine, a neuronal ... patients with partial-onset seizures. In addition, the European Medicines ...
... , , , ... and online presence specifically created to help ease employment stress ... of "The Happy Hour Effect(TM) Balance Plan" just in time ... http://www.newscom.com/cgi-bin/prnh/20091130/CG16928LOGO ) , This synergistic program consists of ...
... working out to avoid cardiac emergency , WEDNESDAY, Dec. 30 ... brings a surge in colds and flu. But did you ... , Frigid air causes blood vessels to constrict as the ... director of education and outreach at the Ronald O. Perelman ...
... , ... Bariatric Advantage, the market leader in peri-operative nutritional support products ... to over 350 patients in 2009! The program named RECOVER has ... every state in the union participating in this program. The programs ...
Cached Medicine News:Health News:AARP Commends Idaho for Tackling Wrongfully Denied Health Claims 2Health News:Bariatric Advantage, a Division of Catalina Lifesciences, Inc. Announces Appointment of Bret Petkus to Vice-President of North American Sales. 2Health News:FDA Accepts NDA Filing for Retigabine 2Health News:New Year's Resolutions Just Got Easier - Happy Hour Effect LLC to Launch 'The Happy Hour Effect(TM) Balance Plan' in 2010 2Health News:New Year's Resolutions Just Got Easier - Happy Hour Effect LLC to Launch 'The Happy Hour Effect(TM) Balance Plan' in 2010 3Health News:Heart Attacks More Common in Winter 2Health News:Bariatric Advantage Sets a Milestone in "Giving" with RECOVER Program Reaching Hundreds of Needy Weight Loss Surgery Patients in 2009 2
(Date:1/23/2015)... and BOSTON , January 23, 2015 ... discovery and development company, is delighted to announce that the ... awarded to Miles Congreve (Vice President of Chemistry), ... Malcolm Weir (Chief Executive Officer and co-founder) for ...
(Date:1/22/2015)... privately held medical device company, announced today that it ... Corporation (Tokyo Stock Exchange TYO: 8001) to sell its ... in Japan . ViewRay,s technology, the ... MRI-guided radiation therapy system that images and treats cancer ...
(Date:1/22/2015)... UPI ), a medical device company that develops, ... dysfunctions, today reported financial results for the fiscal 2015 ... for the Company,s Urgent ®  PC Neuromodulation System grew ... as compared to $3.9 million in the third quarter ...
Breaking Medicine Technology:Heptares Scientists to Receive the Malcolm Campbell Memorial Prize for 2015 in Recognition of Their Outstanding Contribution to GPCR Drug Discovery 2Heptares Scientists to Receive the Malcolm Campbell Memorial Prize for 2015 in Recognition of Their Outstanding Contribution to GPCR Drug Discovery 3Heptares Scientists to Receive the Malcolm Campbell Memorial Prize for 2015 in Recognition of Their Outstanding Contribution to GPCR Drug Discovery 4ITOCHU Named the Exclusive Distributor for ViewRay's MRI-Guided Radiation Therapy System in Japan 2Uroplasty Reports Record Revenue in Fiscal Third Quarter 2Uroplasty Reports Record Revenue in Fiscal Third Quarter 3Uroplasty Reports Record Revenue in Fiscal Third Quarter 4Uroplasty Reports Record Revenue in Fiscal Third Quarter 5Uroplasty Reports Record Revenue in Fiscal Third Quarter 6Uroplasty Reports Record Revenue in Fiscal Third Quarter 7Uroplasty Reports Record Revenue in Fiscal Third Quarter 8Uroplasty Reports Record Revenue in Fiscal Third Quarter 9Uroplasty Reports Record Revenue in Fiscal Third Quarter 10Uroplasty Reports Record Revenue in Fiscal Third Quarter 11Uroplasty Reports Record Revenue in Fiscal Third Quarter 12Uroplasty Reports Record Revenue in Fiscal Third Quarter 13Uroplasty Reports Record Revenue in Fiscal Third Quarter 14Uroplasty Reports Record Revenue in Fiscal Third Quarter 15Uroplasty Reports Record Revenue in Fiscal Third Quarter 16Uroplasty Reports Record Revenue in Fiscal Third Quarter 17Uroplasty Reports Record Revenue in Fiscal Third Quarter 18
... 2011 Niiki Pharma announced today that it will ... study for its lead product, NKP-1339, at the 2011 ... NKP-1339 is a novel transferrin targeted ruthenium based anti-cancer ... key regulator of mis-folded protein processing. In preclinical studies, ...
... On August 1-3, 2011, coinciding with National Convenient ... the Convenient Care Association will present the 4th annual ... the Gaylord Palms hotel in Orlando, Fla. ... education conference designed specifically for the growing field of ...
Cached Medicine Technology:Novel First-in-Class Anti-Cancer Agent in Development by Niiki Pharma Shows Promising Phase I Results 22011 Retail Clinician Education Congress to Offer Exclusive Accreditation and Networking Opportunities for Retail Healthcare Professionals 2
...
The PICO50 is used for arterial line sampling....
The PICO70 is a self-filling sampler for arterial puncture....
... never handled like this before. ... mind, the Spiroflex catheters unique ... and hydrophilic coating provide outstanding ... in with ease and track ...
Medicine Products: